With our innovative gene therapy Learn how
Cure lactose intolerance with a single use treatmentOur focus
We focus on making it safer than drinking milk
Gene Therapies are Already In Use
Gene Therapy isn't just a futuristic concept but a present day reality. Numerous patients are benefiting from gene therapy treatments that are available today. There are an increasing number of gene therapy treatments in the market, and in clinical trials phase.
Both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have given their nod of approval for multiple gene therapies, underscoring the safety and efficiency profile of gene therapies.
Gene therapy offers a long-term solution. Instead of relying on daily medications or dietary restrictions, patients can experience lasting relief from their symptoms.
Quality of Life
For patients, the benefits are profound. No more avoiding dairy or suffering in silence. With gene therapy, they can enjoy a diverse diet and lead a life free from the constant worry of food-induced discomfort.
We are working together with
And are supported by
Still not sure?
Answers to common questions we get.
Our gene therapy uses Adeno-Associated Viruses (AAVs), which are proven to have low genotoxicity and typically do not lead to severe immune responses after administration. We undergo rigorous testing and clinical trials to ensure its safety. We adhere to international safety standards and work closely with regulatory bodies to ensure the highest level of safety for our patients.
The duration of the treatment's effect varies among individuals. However, our preliminary data suggests that the benefits can last for several years. We continue to monitor and study the long-term effects to provide more accurate estimates.
We are committed to making our treatment affordable and accessible. The final cost will be determined closer to the product launch, taking into consideration factors like production costs and market demand. Familiarity of local cuisines, language barriers, and limited access to lactose-free options can make vacations stressful and less enjoyable.
Our gene therapy utilizes Adeno-Associated Viruses (AAVs) to transfer a DNA plasmid into the nucleus of target cells in the small intestine. This process does not alter or integrate into your existing genome. Instead, it provides the cells with the necessary genetic information to address lactose intolerance without changing your overall genetic makeup.
No. The therapy modifies somatic cells (non-reproductive cells) and does not affect your reproductive cells or DNA. Therefore, any genetic modifications will not be inherited by your children.
We are making significant progress in our research and development. While we cannot provide an exact date, we aim to have our product available within the next few years, pending regulatory approvals.
Once approved, our treatment will be available through licensed healthcare providers. We will provide more details on purchasing and distribution closer to the product launch.
Are you ready to be part of the future?
Be part of the future
Our commitment in eradicating lactose intolerance is fueled by a dedicated team of experts who bring diverse skills. We invite you to join us in this journey, whether you have questions, ideas, or simply wish to connect. Let's work together towards a healthier future.Partner with us
Join the cause
Dive into our mission at Milky Way Biotech and champion a transformative breakthrough in lactose intolerance treatment. Your passion and skills can be the driving force behind a brighter, healthier future.Join the team